γδ T CELLS MEDIATE IMMUNOTHERAPY RESPONSE IN HLA CLASS I-DEFICIENT CANCERS

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2023年 / 13卷 / 03期
关键词：
D O I：
10.1158/2159-8290.CD-RW2023-012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
γδ T cells contribute to the efficacy of immunotherapy in the absence of antigen presentation. ©2023 American Association for Cancer Research.
引用
收藏
页码：528 / 528
页数：1
相关论文
共 50 条
  • [21] MHC class I-deficient tumours and their effective chemo-immunotherapy using 5-azacytidine treatment
    Reinis, Milan
    Simova, Jana
    Pollakova, Veronika
    Indrova, Marie
    Mikyskova, Romana
    Stepanek, Ivan
    Bieblova, Jana
    Bubenik, Jan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 : S43 - S43
  • [22] Development of CD8α/α and CD8α/β T cells in major histocompatibility complex class I-deficient mice
    Das, G
    Janeway, CA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06): : 881 - 884
  • [23] HLA class I antigen processing machinery defects in malignant cells and response to immunotherapy with checkpoint inhibitors
    Ferrone, Soldano
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [24] Coordinated downregulation of APM components in MHC class I-deficient metastatic tumour variants immunoselected by T lymphocytes
    Martinez, M
    Garcia-Lora, AM
    Algarra, I
    Jimenez, E
    Garrido, F
    GENES AND IMMUNITY, 2003, 4 : S32 - S32
  • [25] Loss of TAP1 and LMP2 gene expression in HLA class I-deficient tumor cell lines
    Ye, M
    Snider, DP
    Singal, DP
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : P65 - P65
  • [26] MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment
    Elliott, Julie M.
    Wahle, Joseph A.
    Yokoyama, Wayne M.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (10): : 2073 - 2079
  • [27] HLA class I expression on human cancer cells - Implications for effective immunotherapy
    Tait, BD
    HUMAN IMMUNOLOGY, 2000, 61 (02) : 158 - 165
  • [28] Response to UV-C radiation in topo I-deficient carrot cells with low ascorbate levels
    Balestrazzi, A.
    Locato, V.
    Bottone, M. G.
    De Gara, L.
    Biggiogera, M.
    Pellicciari, C.
    Botti, S.
    Di Gesu, D.
    Dona, M.
    Carbonera, D.
    JOURNAL OF EXPERIMENTAL BOTANY, 2010, 61 (02) : 575 - 585
  • [29] INCREASED GAMMA-DELTA T-LYMPHOCYTE RESPONSE TO MYCOBACTERIUM-BOVIS BCG IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-DEFICIENT MICE
    MULLER, D
    PAKPREO, P
    FILLA, J
    PEDERSON, K
    CIGEL, F
    MALKOVSKA, V
    INFECTION AND IMMUNITY, 1995, 63 (06) : 2361 - 2366
  • [30] INDEFINITE SURVIVAL OF MHC CLASS I-DEFICIENT MURINE PANCREATIC-ISLET ALLOGRAFTS
    MARKMANN, JF
    BASSIRI, H
    DESAI, NM
    ODORICO, JS
    KIM, JI
    KOLLER, BH
    SMITHIES, O
    BARKER, CF
    TRANSPLANTATION, 1992, 54 (06) : 1085 - 1089
12345